No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More
Alaunos Therapeutics | 10-Q: Q3 2024 Earnings Report
Express News | Shares in Alaunos Therapeutics Inc Hit Session Low With Volume Spike, Last Down 7.8% at $2
Precigen Terminates License Agreement With Alaunos Therapeutics
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
Express News | Alaunos Therapeutics : Co Provided Written Notice to Precigen to Terminate a&R License Agreement